Literature DB >> 21415532

Curcumin attenuates lipopolysaccharide-induced renal inflammation.

Fang Zhong1, Hui Chen, Lin Han, Yuanmeng Jin, Weiming Wang.   

Abstract

Renal inflammation is the main pathological change in many acute and chronic kidney diseases. Curcumin, a yellow pigment present in the rhizome of turmeric (Curcuma longa L. Zingiberaceae), was found to be a potential anti-inflammatory agent. The present study aimed to investigate the effects of curcumin on the inflammation of mice kidney and cultured renal tubular epithelial cells (HK-2 cells) induced by lipopolysaccharide (LPS) and to explore the mechanism. Curcumin was injected intraperitoneally before LPS administration. Renal inflammation was assessed by evaluating monocyte chemoattractant protein-1 (MCP-1) expression and macrophage infiltration in renal tissue using immunohistochemical methods, and also by measuring renal MCP-1 mRNA level using Real-Time polymerase chain reaction (PCR). HK-2 cells were cultured to investigate the in vitro effect of curcumin against LPS-induced renal inflammation. The expression of MCP-1 and interleukin-8 (IL-8) mRNA was measured by Real-Time PCR. The expression of MCP-1 and IL-8 protein in supernatant was detected by enzyme-linked immunosorbent assay (ELISA). The activity of nuclear factor (NF)-κB was detected by electrophoretic mobility shift assay (EMSA). The results demonstrated that curcumin could inhibit LPS-induced renal MCP-1 mRNA expression. Curcumin also significantly inhibited the expression of MCP-1 and IL-2 mRNA in HK-2 cells, and partially inhibited the secretion of MCP-1 and IL-8. Furthermore, curcumin was found to inhibit the DNA-binding activity of NF-κB. The present study demonstrated that curcumin has a protective effect on LPS-induced experimental renal inflammation, and this effect might be attributed to its inhibitory effects on MCP-1 mRNA expression and DNA-binding activity of NF-κB. Hence, curcumin might be potentially useful in some kidney diseases by preventing renal inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415532     DOI: 10.1248/bpb.34.226

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  22 in total

1.  Quantitative biodistribution and pharmacokinetics of multimodal gadolinium-based nanoparticles for lungs using ultrashort TE MRI.

Authors:  Andrea Bianchi; Sandrine Dufort; François Lux; Arnaud Courtois; Olivier Tillement; Jean-Luc Coll; Yannick Crémillieux
Journal:  MAGMA       Date:  2013-10-30       Impact factor: 2.310

Review 2.  Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection.

Authors:  Youngmin Bu; Kyungjin Lee; Hyuk-Sang Jung; Sang-Kwan Moon
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

3.  Analysis of the gene expression profile of curcumin-treated kidney on endotoxin-induced renal inflammation.

Authors:  Fang Zhong; Hui Chen; Yuanmeng Jin; Shanmai Guo; Weiming Wang; Nan Chen
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

4.  Curcumin Nanoparticles Attenuate Production of Pro-inflammatory Markers in Lipopolysaccharide-Induced Macrophages.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Paul M Young; Ramin Rohanizadeh; Daniela Traini
Journal:  Pharm Res       Date:  2015-09-09       Impact factor: 4.200

5.  In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.

Authors:  Christina N Ramirez; Wenji Li; Chengyue Zhang; Renyi Wu; Shan Su; Chao Wang; Linbo Gao; Ran Yin; Ah-Ng Kong
Journal:  AAPS J       Date:  2017-12-20       Impact factor: 4.009

6.  Curcumin attenuates inflammation and cell apoptosis through regulating NF-κB and JAK2/STAT3 signaling pathway against acute kidney injury.

Authors:  Hongkun Zhu; Xinjun Wang; Xiaoxiao Wang; Bei Liu; Yizhen Yuan; Xiangrong Zuo
Journal:  Cell Cycle       Date:  2020-07-02       Impact factor: 4.534

7.  Renoprotective Roles of Curcumin.

Authors:  Habib Yaribeygi; Mina Maleki; Muhammed Majeed; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Correction to: In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.

Authors:  Christina N Ramirez; Wenji Li; Chengyue Zhang; Renyi Wu; Shan Su; Chao Wang; Linbo Gao; Ran Yin; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2018-02-06       Impact factor: 4.009

9.  MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4.

Authors:  Yuanyuan Kang; Ying Zhang; Yan Sun
Journal:  Int J Oncol       Date:  2021-05-13       Impact factor: 5.650

10.  Suppression of experimental choroidal neovascularization by curcumin in mice.

Authors:  Ping Xie; WeiWei Zhang; Songtao Yuan; Zhiqiang Chen; Qin Yang; DongQing Yuan; Feng Wang; QingHuai Liu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.